Commentary: Global Alzheimer’s Disease and Alzheimer’s-Related Dementia Research Funding Organizations Support and Engage the Research Community Throughout the COVID-19 Pandemic


This article was originally published here

Alzheimer dementia. October 1, 2021. doi: 10.1002 / alz.12472. Online ahead of print.


The COVID-19 pandemic has disproportionately affected the most vulnerable populations, including people with dementia. More than 50 million people around the world are living with Alzheimer’s disease (AD) or other forms of dementia, and it is crucial to continue the fight against this disease during the global pandemic. Since the mandatory closures began in March 2020, charities and nonprofits that fund AD and related dementia research continue to meet the needs of the AD research community, ensuring the momentum continues. and accelerates. Members of the International Alzheimer’s and Related Dementia Research Funder Consortium, a group of nearly 40 funding organizations that meet informally throughout the year to share updates and information, took a certain number of steps to ensure continued support from the research community. Even in uncertain times, it is essential for the field to move forward to uncover prevention, diagnosis and treatment for these diseases that affect millions of people around the world.

PMID: 34596318 | DOI: 10.1002 / alz.12472


About Author

Comments are closed.